gene

ABCA7

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ABCA7: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

591Connections
2Hypotheses
1Analyses
50Outgoing
50Incoming

No summary available yet. View on Wiki →

🧬 Gene Info
Gene SymbolABCA7
Chromosome19q13
FunctionABCA7 encodes ATP-binding cassette transporter A7, a member of the ABC transporter family.
Primary Expressionimmune cells and the brain, where it plays important roles in lipid transport and cellular homeostasis
Subcellular Localizationand processing of APP, potentially increasing amyloidogenic cleavage pathways
PathwaysCholesterol, Glycolysis, Immune Response, Lipid Metabolism, Nf-Κb
Ensembl IDENSG00000064687
GeneCardsABCA7
Human Protein AtlasABCA7
Associated DiseasesALZHEIMER'S DISEASE, Als, Alzheimer, Atherosclerosis
InteractionsNPY, CASS4, EPHA1, CLU, BIN1, CD33
KG Connections591 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

ABCA7 (Redirect)

redirect · 627 words

neuroinflammation

mechanism · 5462 words

Epigenetic Alterations in Alzheimer's Disease

mechanism · 4331 words

Amyloid Cascade Pathway

mechanism · 4149 words

Tauopathies

mechanism · 4072 words

Amyloid-Beta Aggregation and Plaque Formation

mechanism · 3820 words

Pathway Diagram

graph TD
    ABCA7["ABCA7"] -->|"modulates"| Cholesterol_Transport["Cholesterol Transport"]
    ABCA7["ABCA7"] -->|"associated"| APOE["APOE"]
    ABCA7["ABCA7"] -->|"associated"| Alzheimer["Alzheimer"]
    ABCA7["ABCA7"] -->|"associated"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
    ABCA7["ABCA7"] -->|"associated"| TREM2["TREM2"]
    ABCA7["ABCA7"] -->|"associated"| ALZHEIMER["ALZHEIMER"]
    ABCA1["ABCA1"] -->|"associated"| ABCA7["ABCA7"]
    PLCG2["PLCG2"] -->|"associated"| ABCA7["ABCA7"]
    TREM2_1["TREM2"] -->|"regulates"| ABCA7["ABCA7"]
    NEURODEGENERATION["NEURODEGENERATION"] -->|"protects against"| ABCA7["ABCA7"]
    style ABCA7 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0

Outgoing (457)

TargetRelationTypeStr
ds-f50762b67605provides_data_fordataset1.00
ds-83b31ef18d49provides_data_fordataset1.00
ds-db4a006ea647provides_data_fordataset1.00
Macrophagesexpressed_incell_type0.95
Alzheimer's Diseaserisk_factor_fordisease0.95

Incoming (134)

SourceRelationTypeStr
ALZHEIMER'S DISEASEassociated_withdisease1.00
ds-f50762b67605data_indataset1.00
ds-83b31ef18d49data_indataset1.00
ds-db4a006ea647data_indataset1.00
AMYLOIDassociated_withprotein0.82

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
CSF Biomarker-Guided ABCA7 Therapeutic Dosing 0.619 neurodegeneration Why does the V1613M variant reduce amylo
ABCA7-TREM2 Co-Targeting for Microglial Lipid Handling 0.538 neurodegeneration Why does the V1613M variant reduce amylo

Mentioning Analyses (1)

Scientific analyses that reference this entity

Why does the V1613M variant reduce amyloid pathology when ABCA7 loss-of-function

neurodegeneration | 2026-04-14 | 2 hypotheses Top: 0.619

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found